AliveCor Revenue and Competitors
Estimated Revenue & Valuation
- AliveCor's estimated annual revenue is currently $67.5M per year.
- AliveCor's estimated revenue per employee is $478,413
- AliveCor's total funding is $154.3M.
- AliveCor has 141 Employees.
- AliveCor grew their employee count by -25% last year.
AliveCor Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is AliveCor?
AliveCor, Inc. is pioneering the creation of FDA-cleared machine learning techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared KardiaMobile is the most clinically validated mobile EKG solution on the market. It is recommended by leading cardiologists and used by people worldwide for accurate EKG recordings. KardiaMobile, and KardiaBand, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG. Kardia is the first A.I. enabled platform to help clinicians manage patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia and one that leads to a five times greater risk of stroke. KardiaBand is the first FDA-cleared medical device accessory for Apple Watch. AliveCor is recognized by FastCompany as 2018's No. 1 most innovative company in artificial intelligence. AliveCor is a privately-held venture backed company headquartered in Mountain View, Calif. For more information, visit alivecor.com.keywords:Medical Devices, Technology, Digital Health
Number of Employees
Employee Growth %
AliveCor claims that its productsthe ECG-wristband hardware and software and its heart rate analysis apphelped change the perception of the...
?3AliveCor's FDA-cleared, AI-enabled KardiaMobile 6L ECG device aids in the efficient detection of atrial fibrillation,4 as well as the...
However, AliveCor's separate claim that Apple has an illegal monopoly over ECG-capable wearable technology was dismissed. AliveCor has been...
November 16, 2020 – AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, today announced their $65 million series E financing led by existing investors OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures and Bold Capital Partners. P ...
Shortly after raising $65 million to grow its remote monitoring platforms, AliveCor has secured FDA clearance for its new generation of ECG-reading algorithms that spot a wider range of arrhythmias and potential heart conditions. Sponsored by Agilent Technologies How would you like to win free ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|